CELF6-affected TP53 and CD44 at the AS levels are associated with apoptosis, migration signaling pathways, which are associated with oncogenesis, cancer metastasis, prognosis, and total survival in many cancers (Han et al., 2003; Li et al., 2016; Roudi et al., 2014). Here, TP53 is linked to cancer.